Notice2021-16162
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
July 29, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 143 (Thursday, July 29, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 143 (Thursday, July 29, 2021)]
[Notices]
[Pages 40862-40863]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-16162]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; IMAT Biospecimen Research.
Date: September 30, 2021.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W246, Rockville, Maryland 20850, 240-276-5460,
<a href="/cdn-cgi/l/email-protection#036965626d64436e626a6f2d6d6a6b2d646c75"><span class="__cf_email__" data-cfemail="5c363a3d323b1c313d353072323534723b332a">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-2: NCI Clinical and Translational Cancer Research.
Date: October 20-21, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W264, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W264, Rockville, Maryland 20850, 240-276-7286,
<a href="/cdn-cgi/l/email-protection#2e5d4f42585b4d4d416e434f47420040474600494158"><span class="__cf_email__" data-cfemail="aeddcfc2d8dbcdcdc1eec3cfc7c280c0c7c680c9c1d8">[email protected]</span></a>.
Name of Committee: National Cancer Institute Initial Review
Group; Transition to Independence Study Section (I).
Date: October 20-21, 2021.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W602, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Delia Tang, M.D., Scientific Review Officer,
Resources and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W602, Rockville, Maryland 20850, 240-276-6456,
<a href="/cdn-cgi/l/email-protection#186c79767f7c587579717436767170367f776e"><span class="__cf_email__" data-cfemail="99edf8f7fefdd9f4f8f0f5b7f7f0f1b7fef6ef">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-3: NCI Clinical and Translational Cancer Research.
Date: October 21-22, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W102, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Shuli Xia, Ph.D., Scientific Review Officer,
Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W102, Rockville, Maryland 20850,
<a href="/cdn-cgi/l/email-protection#62110a170e0b4c1a0b03220c0b0a4c050d14"><span class="__cf_email__" data-cfemail="35465d40595c1b4d5c54755b5c5d1b525a43">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-8: NCI Clinical and Translational Cancer Research.
Date: November 4-5, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W126, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Susan Lynn Spence, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W126, Rockville, Maryland 20850,
<a href="/cdn-cgi/l/email-protection#13606660727d3d6063767d7076537d7a7b3d747c65"><span class="__cf_email__" data-cfemail="1f6c6a6c7e71316c6f7a717c7a5f71767731787069">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-4: NCI Clinical and Translational Cancer Research.
Date: November 4-5, 2021.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Eduardo Emilio Chufan, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850, 240-276-7975,
<a href="/cdn-cgi/l/email-protection#02616a7764636c6767426f636b6e2c6c6b6a2c656d74"><span class="__cf_email__" data-cfemail="e182899487808f8484a18c80888dcf8f8889cf868e97">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction;
[[Page 40863]]
93.393, Cancer Cause and Prevention Research; 93.394, Cancer
Detection and Diagnosis Research; 93.395, Cancer Treatment Research;
93.396, Cancer Biology Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399, Cancer Control, National
Institutes of Health, HHS)
Dated: July 26, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-16162 Filed 7-28-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on July 29, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.